Unresectable Pancreatic Cancer
Oncology
Prevalence
8.0 / 100K
Incidence
13.1 / 100K/yr
1 drug in development·1 company·6 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| Tripegfilgrastim | KYNTRA BIO INC. (KYNB) |
Frequently asked questions
How many drugs are in development for Unresectable Pancreatic Cancer?
BioSniper tracks 1 drug in development for Unresectable Pancreatic Cancer across 1 company.
How many clinical trials target Unresectable Pancreatic Cancer?
There are 6 clinical trials targeting Unresectable Pancreatic Cancer tracked by BioSniper.
What is the prevalence of Unresectable Pancreatic Cancer?
The estimated prevalence of Unresectable Pancreatic Cancer is approximately 8.0 per 100,000 population.
Deep-dive into Unresectable Pancreatic Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis